(PharmaNewsWire.Com, May 26, 2017 ) Market Research Hub, the industry analysis specialist, has released its new report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Spain”. The report is an essential source of information and analysis on Spain’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and the country’s healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the Spanish pharmaceutical and medical device markets.
The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by MRH’s team of industry experts.
Spain’s population was 47.1 million in 2012, but it is decreasing due to a negative balance between the birth and death rate, as well as a negative migration balance.
The country’s policymakers are currently faced with the challenge of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market at the pharmacy retail price was estimated to be worth $24.8 billion in 2012, and is expected to reach $29.4 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 0.6%. The medical devices market was estimated at approximately $7 billion in 2012, and is expected to reach $11.9 billion by 2020 at a CAGR of 4.8%.
Scope:
An overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market, comprising Pfizer, F. Hoffmann-La Roche, Novartis, Sanofi and Eli Lilly; and medical devices market, comprising Abbott Laboratories, F. Hoffmann-La Roche, Medtronics, GE Healthcare and Siemens Healthcare
An insightful review of the country’s reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
An overview of the opportunities for and challenges to growth in the healthcare market
Reasons To Buy:
Develop business strategies by understanding the trends shaping and driving Spain’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Spain’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Identify, understand and capitalize on the opportunities and challenges in Spain’s healthcare market
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of Healthcare Market Research Reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
